Walgreens Boots Alliance (NASDAQ:WBA) issued its quarterly earnings results on Wednesday. The pharmacy operator reported $1.22 earnings per share for the quarter, beating analysts’ consensus estimates of $1.03 by $0.19, MarketWatch Earnings reports. The business had revenue of $36.31 billion during the quarter, compared to analyst estimates of $35.01 billion. Walgreens Boots Alliance had a net margin of 0.33% and a return on equity of 18.33%. Walgreens Boots Alliance’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same quarter last year, the business posted $1.37 earnings per share.
Shares of NASDAQ:WBA traded down $0.13 during midday trading on Friday, reaching $45.13. 432,921 shares of the company were exchanged, compared to its average volume of 11,145,039. Walgreens Boots Alliance has a fifty-two week low of $33.36 and a fifty-two week high of $56.80. The company has a quick ratio of 0.32, a current ratio of 0.67 and a debt-to-equity ratio of 0.58. The stock has a fifty day simple moving average of $40.18 and a two-hundred day simple moving average of $39.23. The firm has a market cap of $38.99 billion, a PE ratio of 91.50, a P/E/G ratio of 1.52 and a beta of 0.44.
The company also recently declared a quarterly dividend, which was paid on Friday, December 11th. Stockholders of record on Thursday, November 19th were given a dividend of $0.4675 per share. The ex-dividend date was Wednesday, November 18th. This represents a $1.87 dividend on an annualized basis and a dividend yield of 4.14%. Walgreens Boots Alliance’s dividend payout ratio is 39.45%.
A number of analysts recently weighed in on WBA shares. Zacks Investment Research raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating and set a $39.00 price target for the company in a report on Saturday, November 7th. Barclays raised their price objective on shares of Walgreens Boots Alliance from $40.00 to $47.00 and gave the company an “equal weight” rating in a research note on Friday. Credit Suisse Group initiated coverage on shares of Walgreens Boots Alliance in a research note on Thursday. They issued a “neutral” rating on the stock. BidaskClub cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Friday, December 18th. Finally, Bank of America reaffirmed a “sell” rating and issued a $37.00 price objective on shares of Walgreens Boots Alliance in a research note on Wednesday, October 7th. Four research analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the company. Walgreens Boots Alliance currently has a consensus rating of “Hold” and an average price target of $42.31.
In related news, CAO Marco Patrick Anthony Pagni sold 5,000 shares of the firm’s stock in a transaction on Wednesday, November 11th. The shares were sold at an average price of $41.55, for a total transaction of $207,750.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 16.91% of the company’s stock.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.
Featured Article: Do You Need a Fiduciary?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.